Innovative drug discovery strategies in epilepsy: integrating next-generation syndrome-specific mouse models to address pharmacoresistance and epileptogenesis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Innovative drug discovery strategies in epilepsy: integrating next-generation syndrome-specific mouse models to address pharmacoresistance and epileptogenesis

Published:2024-07-29 Issue:9 Volume:19 Page:1099-1113
ISSN:1746-0441
Container-title:Expert Opinion on Drug Discovery
language:en
Short-container-title:Expert Opinion on Drug Discovery

Author:

Barker-Haliski Melissa¹^ORCID,Hawkins Nicole A²^ORCID

Affiliation:

1. Pharmaceutics, University of Washington, Seattle, WA, USA

2. Feinberg School of Medicine Chicago, Northwestern University, Chicago, IL, USA

Funder

National Institutes of Health

National Institute of Neurological Disorders and Stroke

Institute of Aging

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/17460441.2024.2384455

Reference158 articles.

1. The new definition and classification of seizures and epilepsy

2. New avenues for anti-epileptic drug discovery and development

3. Treatment Outcomes in Patients With Newly Diagnosed Epilepsy Treated With Established and New Antiepileptic Drugs

4. Antiepileptogenesis and Seizure Prevention Trials with Antiepileptic Drugs: Meta-Analysis of Controlled Trials

5. Antiepileptogenic Agents

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP